Clinical Trial Update: Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of oral ferric maltol for iron deficiency anemia in chronic kidney disease completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• Ferric Maltol (ferric maltol)

Snippet

Sponsor: Shield Therapeutics | Conditions: Renal Insufficiency, Chronic, Iron-Deficiency Anemia | Phase 3 | Status: COMPLETED | Results posted: 2020-05-01